History & Research

Halotherapy has its origins from the salt mines in Europe and Russia. Considering that mining jobs were recognized as dangerous to life and health, salt miners rarely suffered from any colds, respiratory ailments or lung diseases. It was discovered that the mining work of chiseling, grinding and hammering of the salt released micro-sized particles that were being disbursed into the air.

Upon studying the effects of this phenomena, Dr. Feliks Boczkowski founded and opened the first underground health facility at the Wieliczka Salt Mine in Poland in 1839. People with asthma, allergies, emphysema began heading to the salt mines for treatment.

About 25 years ago, a group of medical experts in St. Petersburg found a way to blow salt into an indoor reproduction of salt mines, creating a dry salt microclimate. It was named “Halotherapy” from the original Greek word, “halite”, meaning rock salt.

The long-term experience in development has led to today’s standard of a controlled aerosol level during the course of a 45-minute session, ensuring a correct dosage of pure grade sodium chloride aerosol via a Halogenerator generator.

Studies have been done in Russia, Finland, Italy, Poland. A 1995 study in the Journal of Aerosol Medicine showed 97 percent improvement for chronic bronchitis and 85 percent improvement in mild to moderate asthma, and Halotherapy’s been sanctioned by the Russian Ministry of Public health since 1990.

Although Halotherapy is new to the U.S., it is frequently used in many countries of Eastern Europe and all over the world as a natural alternative and complementary way of improving general wellness, respiratory issues, skin conditions, detoxification, athletic and musical performance. The Salt Therapy Association has compiled several research articles and studies posted below. We will be constantly adding new research, information, and feedback here and encourage all members to provide feedback as well.

1) The use of Halotherapy for the rehabilitation of patients with acute bronchitis and a protracted and recurrent course. (Borisenko LV, Chervinskaia AV, Stepanova NG, Luk’ian VS, Goncharova VA, PokhodzeT IV, Krivitskaia VZ, Vishniakova LA, Pokhaznikova MA, Faustova ME,) 1995 Russia


2) The use of an artificial microclimate chamber in the treatment of patients with chronic obstructive lung diseases (Chernenkov RA, Chernenkova EA, Zhukov GV.) 1997 Russia

3) Halotherapy in the combined treatment of chronic bronchitis patients (Maev EZ, Vinogradov NV.) 1999 Russia


4) The scientific validation and outlook for the practical use of halo-aerosol therapy (Chervinskaia AV.) 2000 Russia

5) Halotherapy for treatment of respiratory diseases. (Chervinskaya AV1, Zilber NA). 2000 Russia

6) Effectiveness of Halotherapy of chronic bronchitis patients (Abdrakhmanova LM, Farkhutdinov UR, Farkhutdinov RR.) 2000 Russia

7) Effects of Halotherapy on free radical oxidation in patients with chronic bronchitis (Farkhutdinov UR, Abdra-khmanova LM, Farkhutdinov RR.) 2000 Russia

8) Efficacy of therapeutic use of ultrasound and sinusoidal modulated currents combed with Halotherapy in patient with occupational toxic-dust bronchitis (Roslaia NA, Likhacheva El, Shchekoldin PI) 2001 Russia

9) The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics (Hedman J1, Hugg T, Sandell J, Haahtela T.) 2006 Finland
http://www.ncbi nlm.nih.gov/pubmed/16629791

10) The use of Halotherapy for the health improvement in children at institutions of general education (Khan MA, Chervinskaia AV, Mikitchenko NA) 2012 Russia

11) Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases. (Gelardi Ml, lannuzzi L, Greco Miani A, Cazzaniga S, Naldi L, De Luca C, Quaranta N) 2013 Italy

12) Salt caves as simulation of natural environment and significance of Halotherapy. (Zajac J1, Bojar 12, Helbin J1, Kolarzyk El, Owoc A3) 2014 Poland